Abstract:Highlights • Optimized OFDF formulation applicable to a broad range of drugs. • Experimental design using a 3 3 full factorial Box-Behnken design. • Formulation development for co-administration of two phytochemicals. • Utilization of co-amorphous dual-drug systems to enchance film morphology and drug dissolution. • Better in vitro performance with higher drug payload and less excipients. • A streamlined approach for improving the dissolution of insoluble drugs. Oral fast dissolving films (OFDFs) are popular dosage forms for enhanced oral absorption of active ingredients without experiencing gastrointestinal interference or first-pass metabolism. The primary challenge in OFDF design is balancing drug loading capacity with film properties, particularly for poorly soluble drugs. In the present work, an OFDF formulation containing co-amorphous mixture was successfully designed for co-administration of two natural products at a drug content of 14%. Breviscapine and matrine are commonly used for cardiovascular and cerebrovascular related diseases, but their clinical application was limited by low bioavailability, short biological half-life, and instability problems. Their co-administration as a compound remedy requires a novel product too enhance drug dissolution and patient compliance. A 3 3 Box-Behnken design was used to generate OFDF preparations by solvent casting method. The optimized blank film formulation, comprising 57.40% HPMC E50, 14.01% PEG 400 and 5.35% L-HPC, demonstrated a rapid disintegration in 18 seconds. XRD and FTIR analysis on drug-loaded films revealed good compatibility of drugs and polymers, and amorphous state of films with co-precipitates. The films were evaluated for morphology, folding endurance, disintegration time and in vitro BRE dissolution. Drugs incorporation extended the disintegration time of blank films, yet remained under 30 seconds. The co-amorphous mixture of BRE and MAT in films exhibited a faster BRE dissolution rate compared to the physical mixture. In conclusion, a compound OFDF formulation featuring a co-amorphous mixture of BRE and MAT offers an efficient strategy for hydrophobic drug delivery at high dose. Graphical abstract Download : Download high-res image (290KB) Download : Download full-size image

Dual thermal stabilizing effects of xanthan gums via glycosylation and hydrogen bonding and in vivo human bioavailability of desmopressin in orodispersible film

Thermal stability of exenatide encapsulated in stratified dissolving microneedles during storage

Effect of processing methods on xylitol-starch base co-processed adjuvant for orally disintegrating tablet application

The synergistic gelation of Dendrobium officinale polysaccharide (Dendronans) with xanthan gum and its rheological and texture properties

Evidence from Thermal Aging Indicating That the Synergistic Effect of Glyoxal and Sodium Sulfite Improved the Thermal Stability of Conformational Modified Xanthan Gum

The Effect of Cooling on the Degree of Crystallinity, Solid-State Properties, and Dissolution Rate of Multi-Component Hot-Melt Extruded Solid Dispersions

Enhancing dissolution of domperidone by spray-drying: effect of different storage conditions on stability

Development of Orodispersible Films Containing Benzydamine Hydrochloride Using a Modified Solvent Casting Method

Oral fast dissolving films for co-administration of breviscapine and matrine: Formulation optimization and in vitro characterization

The role of hydrophilic/hydrophobic group ratio of polyvinyl alcohol on the miscibility of amlodipine in orodispersible films: from molecular mechanism study to product attributes

Development and evaluation of an oral fast disintegrating anti-allergic film using hot-melt extrusion technology

Comparison of Oven Dried and Freeze Dried Orally Disintegrating Film (ODF) Formulations Containing Memantine Hydrochloride

Vardenafil Oral Dispersible Films (ODFs) with Advanced Dissolution, Palatability, and Bioavailability

Revolutionizing fast disintegrating tablets: Harnessing a dual approach with porous starch and sublimation technique

Injectable shear-thinning xanthan gum hydrogel reinforced by mussel-inspired secondary crosslinking

Development and in vitro evaluation of an oral SEDDS for desmopressin

Corn fiber gum-soybean protein isolate double network hydrogel as oral delivery vehicles for thermosensitive bioactive compounds

Optimization of taste-masked dapoxetine oral thin films using factorial design: in vitro and in vivo evaluation

In Vitro and In Vivo Evaluation of Hydroxypropyl-β-cyclodextrin-grafted-poly(acrylic acid)/poly(vinyl pyrrolidone) Semi-Interpenetrating Matrices of Dexamethasone Sodium Phosphate

Overcoming Poor Solubility of Dimenhydrinate: Development, Optimization and Evaluation of Fast Dissolving Oral Film

Physicochemical characterization of novel okra mucilage/hyaluronic acid-based oral disintegrating films for functional food applications